- Bupa Platinum consultant
-
Fee assured
-
Verified account
- Open Referral network
Specialises in
- Brain/CNS
- Breast
Offers
- Face-to-face consultations
- Video and telephone consultations
About me
After completing her medical schooling , Dr Mehta did her radiotherapy and oncology training in one of India's most prestigious universities, the Postgraduate Institute of Medical Education and Research in Chandigarh, and was awarded a radiotherapy doctorate, MD in 2005.
She completed her postgraduate medical training in the UK, gaining MRCP UK and MRCP Ireland. After completing four years of research at Churchill Hospital/Weatherall Institute of Molecular Medicine, Oxford, she was awarded PhD Oncology from the University of Oxford in 2014.
Dr Mehta did her specialist training in Clinical Oncology at The Christie Hospital, Manchester, and obtained her FRCR Clinical Oncology in 2017. During her training at The Christie, Dr Mehta was awarded a NIHR academic clinical fellowship and clinical lectureship.
Dr Mehta joined The Clatterbridge Cancer Centre as a consultant clinical oncologist in 2019. She specialises in central nervous system/ Brain cancers and breast cancers. She has an extensive interest in research and is committed to improving outcomes in cancer patients, particularly in brain and breast cancers. She is principal investigator for many national and international clinical trials in these fields.
In 2022 Dr Mehta was appointed Deputy Director of Clinical Research at Clatterbridge.
She was also the Cancer Associate Specialty Lead Cheshire & Merseyside for North west coast CRN from June 2022 to Oct 2024. She has been appointed as NIHR Regional Research Delivery Network North West Specialty co-Lead RSSL for Cancer since Jan 2025.
She is an active member of British Neurooncology Society
(BNOS) , European association of Neurooncology ( EANO) and attend national and international meetings regularly as an expert in her field.
Areas of interest
breast cancer; brain cancers; brain metastasis; stereotactic radiosurgery (SRS) ; advanced radiotherapy; IMRT; VMAT; chemotherapy; targeted treatment; Tumour Treating Field ( TTF or Optune)
Medical secretaries
- Duncan Armfield
- Clatterbridge Private - Clinic Clatterbridge Cancer Hospital 65 Pembroke Place, Liverpool L7 8YA
- 0151 318 8569
- Duncan.Armfield@nhs.net
Information for healthcare professionals (Bupa patients only, last 12 months)
-
X0003
Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-21 days - (1-5)
-
X0005
Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-56 days - (1-5)
-
X0008
Clinical supervision of external beam radiotherapy, for 16 or up to and including 30 fractions - (1-5)
-
X6772
Preparation for complex radiotherapy with Intensity Modulated Radiotherapy (IMRT) - (1-5)
-
X0007
Clinical supervision of external beam radiotherapy, up to and including 15 fractions or part thereof - (1-5)
-
X6930
Clinical supervision of the planning of a course of complex radiotherapy - (1-5)